Faslodex Solution For Injection 250 mg/5ml
Product details
Registration number: SIN13216P
Classification: Prescription Only
Active ingredients: Fulvestrant
Strength: 50 mg/ml
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: L02BA03
HSA approval date: 6 September 2006
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG
- Vetter Pharma-Fertigung GmbH & Co KG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for Faslodex Solution For Injection 250 mg/5ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13216P
Classification: Prescription Only
What active ingredients and strength are recorded for Faslodex Solution For Injection 250 mg/5ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Fulvestrant
Strength: 50 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Faslodex Solution For Injection 250 mg/5ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Who is the recorded registrant for Faslodex Solution For Injection 250 mg/5ml?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for Faslodex Solution For Injection 250 mg/5ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG
- Vetter Pharma-Fertigung GmbH & Co KG
Manufacturing country/countries: GERMANY
Where can I look up Faslodex Solution For Injection 250 mg/5ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13216P or the exact product name Faslodex Solution For Injection 250 mg/5ml. The general register link does not preselect this product.
What are the source dates for this Faslodex Solution For Injection 250 mg/5ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Faslodex Solution For Injection 250 mg/5ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13216P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)